Literature DB >> 22740130

Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome.

Mirza Romero-Valdovinos1, Areli Gudiño-Ramírez, Jesús Reyes-Gordillo, Williams Arony Martínez-Flores, María Elena Ramírez-Miranda, Pablo Maravilla, Angélica Olivo-Díaz.   

Abstract

Irritable bowel syndrome (IBS) is one of the most common gastrointestinal diagnoses seen by primary care providers and gastroenterologists. Proinflammatory cytokines interleukin (IL)-6 and IL-8 have been found increased in IBS patients. Cytokine gene single nucleotide polymorphisms (SNPs) of IL-8 and IL-10 have not been assessed in Mexican IBS patients. DNA was extracted from peripheral blood leucocytes of 45 IBS unrelated patients and 137 controls. Allele, genotype, and haplotype frequencies were determined by analyzing SNPs of IL-8 and IL-10 genes. IL-8 + 396 G allele (P = 0.02), IL-8 + 396(G/G) and IL-8 + 781(C/T) genotypes (P < 0.001), IL-10 - 1082A allele and IL-10 - 1082(A/A) genotype (P < 0.001) were significantly increased in the IBS group. Haplotypes IL-8 ATCC (P = 0.03) and IL-10 ACC (P < 0.001) were associated with susceptibility to develop IBS. An association of certain polymorphisms of IL-8 and IL-10 in IBS patients compared to controls was demonstrated, suggesting a role of these cytokine SNPs in the pathophysiology of IBS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22740130     DOI: 10.1007/s11033-012-1745-2

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  30 in total

1.  SNPStats: a web tool for the analysis of association studies.

Authors:  Xavier Solé; Elisabet Guinó; Joan Valls; Raquel Iniesta; Víctor Moreno
Journal:  Bioinformatics       Date:  2006-05-23       Impact factor: 6.937

2.  The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population.

Authors:  M Ohyauchi; A Imatani; M Yonechi; N Asano; A Miura; K Iijima; T Koike; H Sekine; S Ohara; T Shimosegawa
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component?

Authors:  W M Gonsalkorale; C Perrey; V Pravica; P J Whorwell; I V Hutchinson
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 4.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

5.  Low-grade inflammation plays a pivotal role in gastrointestinal dysfunction in irritable bowel syndrome.

Authors:  Hirotada Akiho; Eikichi Ihara; Kazuhiko Nakamura
Journal:  World J Gastrointest Pathophysiol       Date:  2010-08-15

6.  Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity.

Authors:  Paul Scully; Declan P McKernan; John Keohane; David Groeger; Fergus Shanahan; Timothy G Dinan; Eamonn M M Quigley
Journal:  Am J Gastroenterol       Date:  2010-04-20       Impact factor: 10.864

7.  Increased in vivo transcription of an IL-8 haplotype associated with respiratory syncytial virus disease-susceptibility.

Authors:  D Hacking; J C Knight; K Rockett; H Brown; J Frampton; D P Kwiatkowski; J Hull; I A Udalova
Journal:  Genes Immun       Date:  2004-06       Impact factor: 2.676

8.  The association between cytokine gene polymorphisms and kidney allograft survival.

Authors:  Andrzej Pawlik; Leszek Domanski; Jacek Rozanski; Bogusław Czerny; Zygmunt Juzyszyn; Grazyna Dutkiewicz; Marek Myslak; Maciej Hałasa; Marcin Słojewski; Ewa Dabrowska-Zamojcin
Journal:  Ann Transplant       Date:  2008       Impact factor: 1.530

Review 9.  Genetic determination of irritable bowel syndrome.

Authors:  Cristina Hotoleanu; Radu Popp; Adrian-Pavel Trifa; Laurentiu Nedelcu; Dan-L Dumitrascu
Journal:  World J Gastroenterol       Date:  2008-11-21       Impact factor: 5.742

10.  Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Burkitt's lymphoma cell lines.

Authors:  D Kube; C Platzer; A von Knethen; H Straub; H Bohlen; M Hafner; H Tesch
Journal:  Cytokine       Date:  1995-01       Impact factor: 3.861

View more
  8 in total

Review 1.  Association of interleukin-10 polymorphisms with risk of irritable bowel syndrome: a meta-analysis.

Authors:  Shan-Yu Qin; Hai-Xing Jiang; Dong-Hong Lu; You Zhou
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  Crosstalk at the mucosal border: importance of the gut microenvironment in IBS.

Authors:  Lena Öhman; Hans Törnblom; Magnus Simrén
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-12-02       Impact factor: 46.802

Review 3.  Genetic polymorphism in pathogenesis of irritable bowel syndrome.

Authors:  Cynthia K Y Cheung; Justin C Y Wu
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 4.  Molecular basis of the irritable bowel syndrome.

Authors:  Anna Vaiopoulou; Georgios Karamanolis; Theodora Psaltopoulou; George Karatzias; Maria Gazouli
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 5.  Irritable bowel syndrome: emerging paradigm in pathophysiology.

Authors:  Yoo Jin Lee; Kyung Sik Park
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

Review 6.  Ethnic differences in genetic polymorphism associated with irritable bowel syndrome.

Authors:  Qi-Yun Xiao; Xiu-Cai Fang; Xiao-Qing Li; Gui-Jun Fei
Journal:  World J Gastroenterol       Date:  2020-05-07       Impact factor: 5.742

Review 7.  Gut Microbiota Shifting in Irritable Bowel Syndrome: The Mysterious Role of Blastocystis sp.

Authors:  Alireza Olyaiee; Amir Sadeghi; Abbas Yadegar; Elnaz Sadat Mirsamadi; Hamed Mirjalali
Journal:  Front Med (Lausanne)       Date:  2022-06-20

8.  Chemotactic chemokines are important in the pathogenesis of irritable bowel syndrome.

Authors:  Charles Darkoh; Latoya Comer; Getie Zewdie; Stephen Harold; Ned Snyder; Herbert L Dupont
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.